Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer
Abstract Background Ultrahypofractionation using stereotactic body radiotherapy (SBRT) is an increasingly utilized technique for men with prostate cancer (PC). The comparative efficacy of SBRT plus androgen deprivation therapy (ADT) compared to fractionated radiotherapy (EBRT) plus ADT in higher-ris...
Main Authors: | Sagar A. Patel, Jeffrey M. Switchenko, Ben Fischer-Valuck, Chao Zhang, Brent S. Rose, Ronald C. Chen, Ashesh B. Jani, Trevor J. Royce |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-020-01658-5 |
Similar Items
-
Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer
by: Jonathan Mohajer, et al.
Published: (2021-01-01) -
A cost-outcome analysis of androgen deprivation therapy and androgen deprivation therapy combine radiotherapy for locally advanced prostate cancer
by: Wei-Na Wang, et al.
Published: (2011) -
Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
by: Yeon Joo Kim, et al.
Published: (2020-10-01) -
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
by: Uri Amit, et al.
Published: (2019-06-01) -
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
by: Røe Kathrine, et al.
Published: (2012-05-01)